Immuno-Oncology Combinations in Advanced RCC: Building on Recent Progress

Get up to date on the latest developments in immuno-oncology combinations for advanced RCC with expert-led live simulcasts, an on-demand video Webcast, a downloadable slideset, and Clinical ExpressPoints summary slideset
M. Dror Michaelson, MD, PhD
Robert Motzer, MD

Downloadable Slidesets

Download this short summary slideset of key takeaways from a live CCO series focused on key data for management of patients with RCC.

M. Dror Michaelson, MD, PhD Robert Motzer, MD Released: July 7, 2020

Download this slideset from our live meeting series to learn more about the optimal use of immune-oncology−based therapy for patients with RCC.

M. Dror Michaelson, MD, PhD Robert Motzer, MD Released: June 26, 2020

On-Demand Webcast

In this interactive on-demand Webcast, gain expert perspectives on the latest developments in immuno-oncology combinations for advanced RCC including management of disease-related complications or adverse events.

M. Dror Michaelson, MD, PhD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Physician Assistants: maximum of 1.0 hour of AAPA Category I (Preapproved) credit Pharmacists: 1.0 contact hour (0.1 CEUs) Released: November 4, 2020 Expired: November 3, 2021
Provided by the National Comprehensive Cancer Network in partnership with Clinical Care Options, LLC
NCCN Logo

Karen Kanefield
Manager CE Accreditation & Program Operations
National Comprehensive Cancer Network
3025 Chemical Road, Suite 100
Plymouth Meeting, PA 19462

215-690-0239
215-690-0283 (Fax)
education@nccn.org
For Clinicians:
NCCN.org
For Patients:
NCCN.org/patients

Supported by a medical education grant from Exelixis, Inc.

Supported by an independent educational grant from Merck & Co., Inc.

Supported by educational grants from
Eisai
Pfizer Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue